Catheter-Associated Urinary Tract Infection and Obstinate Biofilm Producers

Table 3

Antibiotic susceptibility of biofilm producer and non-biofilm producers.

Antibiotics	Biofilm producer isolates ()	%	Biofilm nonproducer isolates ()	%	Resistance of all isolates ()	%
Gram-negatives isolates
Ampicillin	24	92.30	28	84.84	52	88.13
Ceftazolin	20	76.92	25	75.75	45	76.27
Gentamicin	14	53.84	11	30.30	25	42.37
Ciprofloxacin	19	73.07	23	69.69	42	71.18
Nitrofurantion	12	46.15	5	15.15	17	28.81
Amikacin	12	46.15	11	33.33	23	38.98
Amoxicillin-clavulanate	25	96.15	24	72.72	49	83.05
Piperacillin-tazobactam	7	26.92	7	21.22	14	23.72
Cefuroxime	20	76.92	24	72.72	44	74.57
Imipenem	5	19.23	1	3.03	6	10.16
Fosfomycin	3	11.5	1	3.03	4	6.77
Meropenem	14	53.84	12	36.36	26	44.06
Tetracyclin	19	73.07	17	51.51	36	61.01
Cotrimoxazol	17	65.38	21	63.63	38	64.40
Ceftazidime	21	80.76	21	63.63	42	71.18
Antibiotics	Biofilm producer isolates ()	%	Biofilm nonproducer isolates ()	%	Resistance of all isolates ()	%
Gram-positive isolates
Ampicillin	2	66.67	1	33.33	3	50
Gentamicin	1	33.33	0	0.00	1	16.67
Ciprofloxacin	1	33.33	0	0.00	1	16.67
Nitrofurantion	1	33.33	0	0.00	1	16.67
Amoxicillin-clavulanate	3	100	1	33.33	4	66.67
Piperacillin-tazobactam	0	0.00	0	0.00	0	0.00
Meropenem	0	0.00	0	0.00	0	0.00
Tetracyclin	3	100	2	66.67	5	83.33
Cloxacillin	3	100	2	66.67	5	83.33
Vancomycin	0	0.00	0	0.00	0	0.00
Fosfomycin	0	0.00	0	0.00	0	0.00